#
Treagan Otic Solution
  • Professionals
  • FDA PI

Treagan Otic Solution

Generic name: antipyrine benzocaine
Dosage form: otic solution
Drug class:Otic anesthetics

Medically reviewed by Drugs.com. Last updated on Mar 22, 2022.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Description

Each ml contains:
acetlc acid..... 0.01%
antipyrine .....5.4%
benzocaine ..... 1.4%
polycosanol 410 (synthetic mixture)..... 0.01%
Also contains aluminum acetate.
Inactive Ingredient: Glycerin.

TOPICAL ANESTHETIC, ANALGESIC AND ANTIBACTERIAL: An otic solution
containing acetic acid, antipyrine, benzocaine, polycosanol410 and aluminum
acetate. The solution congeals at 0oC (32oF) but returns to normal consistency,
unchanged at room temperature. The structures of the components are:


Clinical Pharmacology

Combines the property of acetic acid, polycosanol 410 and aluminum acetate with the analgesic action of antipyrine and the local anesthetic action of benzocaine to relieve pressure, reduce inflammation and
congestion, and alleviate pain and discomfort in acute otitis media. Does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.

Indications and Usage

Acute otitis media of various etiologies
• Prompt relief of pain and reduction of inflammation in the congestIve and
serous stages.
• Adjuvant therapy during systemic antibiotic administration for resolution
of the infection.
Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequent problem especially in children in whom the tube is shorter, wider and more horizontal than in adults.

Removal of cerumen;
• Facilitates the removal of excessive or impacted cerumen.

Contraindications

Hypersensitivity to any of the components or substances related to them. In the presence of spontaneous perforation or discharge.

Precautions

Carcinogenesis, Mutagenesis, Impairment of Fertility: No long-term studies in animals or humans have been conducted.
Pregnancy Category C: Animal reproduction studies have not been condu